An Australian stem cell and regenerative medicine company

June 21, 2022

Cymerus MSCs as a potential stem cell therapy for IPF

A study conducted by Professor Chrishan Samuel, a Monash Biomedicine Discovery Fellow and Head of the Fibrosis Laboratory, Department of Pharmacology at Monash University, found that in an animal model of idiopathic pulmonary fibrosis (IPF), Cynata’s stem cells ameliorated the mediators of lung inflammation while at the same time promoting anti-inflammatory effects. Why is this exciting? 

Learn more